Capsule form is supplied strictly for research design flexibility and is not intended to imply any specific route of administration or biological outcome
Currently, no FDA-approved BPC-157 products exist for human use, making all available formulations research compounds or compounded preparations from licensed pharmacies
The compounds described by PrymaLab including BPC-157, TB-500, NAD+, PT-141 (bremelanotide), Selank, and Semax are sold strictly as research-use-only materials for in-vitro and non-human laboratory study
BV is more effective than adjuvants for treating arthritic pain because of its anti-nociceptive properties (Ullah et al., 2023)
So, it can be easy to confuse them with other performance-enhancing drugs like anabolic steroids, which can also be injected